暫無牌價信息，您可以發(fā)送詢價，我們會盡快給你回復。
| 英文名稱 | Notoginsenoside R1 |
|---|---|
| 中文名稱 | 三七皂苷R1/人參皂苷R1/(2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-(((2R,3R,4S,5S,6R)-4,5-二羥基-6-(羥甲基)-3-(((2S,3R,4S,5R)-3,4,5-三羥基四氫-2H-吡喃-2-基)氧基)四氫-2H-吡喃-2-基)氧基)-3,12-二羥基-4,4,8,10,14-五甲基十六氫-1H-環(huán)戊并[a]菲-17-基)-6-甲基庚-5-烯-2-基)氧基)-6-(羥甲基)四氫-2H-吡喃-3,4,5-三醇/三七皂甙R1 |
| CAS號 | 80418-24-2 |
| 分子式 | C47H80O18 |
| 分子量 | 933.13 |
| 外觀 | 白色粉末 |
| 沸點 | 1010.5±65.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 12.85±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000488
中文名稱：三七皂苷R1
中文別名：人參皂苷R1；(2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-(((2R,3R,4S,5S,6R)-4,5-二羥基-6-(羥甲基)-3-(((2S,3R,4S,5R)-3,4,5-三羥基四氫-2H-吡喃-2-基)氧基)四氫-2H-吡喃-2-基)氧基)-3,12-二羥基-4,4,8,10,14-五甲基十六氫-1H-環(huán)戊并[a]菲-17-基)-6-甲基庚-5-烯-2-基)氧基)-6-(羥甲基)四氫-2H-吡喃-3,4,5-三醇；三七皂甙R1
英文名稱：Notoginsenoside R1
英文別名：(3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-β-D-xylopyranosyl-β-D-glucopyranoside;Dammarane, β-D-glucopyranoside deriv.;Notoginsenoside R1;Sanchinoside R1;Sanqi glucoside R1;
分子式：C47H80O18
分子量：933.13
CAS號：80418-24-2
純度：HPLC≥98%
沸點：1010.5±65.0 °C | Condition: Press: 760 Torr
密度：1.39±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：12.85±0.70 | Condition: Most Acidic Temp: 25 °C
儲存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應客戶需求包裝
供應單位：四川省維克奇生物科技有限公司
供應電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標準品和天然植物有效單體，主打中藥對照品/標準品/天然植物有效單體，化學合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請關注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Discovery of triterpenoids as potent dual inhibitors of pancreatic lipase and human carboxylesterase 1 | ||
| 來源：SCI：JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 作者：Jing Zhang | 備注：影響因子：5.051 |
| 引用描述 | ||
Oleanolic acid, maslinic acid, hederagenin, ursolic acid, corosolic acid, asiatic acid, β-boswellic acid, glycyrrhetic acid, celastrol, betulin, betulinicaldehyde, betulinic acid, pachymic acid, ganoderic acid B, polygalacic acid, glycyrrhizic acid, lupeol, ginsenosideol F1, ginsenoside Rg1, ginsenoside Rg2, were purchased from Dalian Meilun Company (Beijing, China), ginsenoside Rd, ginsenoside R1, Notoginsenoside R1 were purchased from Sichuan Weikeqi Biotechnology Co., Ltd. (Chengdu, China), ginsenoside Re, ginsenoside Rh1 were purchased from Chengdu Pfeid Biotech Technology Co., Ltd. (Chengdu, China), ginsenoside Ro, ginsenoside Rh4, and ginsenoside F4 were purchased from Chenguang Bio (Handan, China). | ||
| Steamed Panax notoginseng attenuates renal anemia in an adenine-induced mouse model of chronic kidney disease | ||
| 來源：SCI：JOURNAL OF ETHNOPHARMACOLOGY | 作者：Min Gao | 備注：影響因子：4.36 |
| 引用描述 | ||
The reference standards of notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rc, 20(S)–Rh1, 20(R)-Rh1, Rd, Rg6, F4, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5, all with a purity ≥98%, were purchased from Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, Sichuan, China). EPO was purchased from Chengdu Di'ao Jiuhong Pharmaceutical Factory (Chengdu, Sichuan, China). FEJ was purchased from Shandong Dong'e E'jiao Co., Ltd. | ||
| Steamed Panax notoginseng Attenuates Anemia in Mice With Blood Deficiency Syndrome via Regulating Hematopoietic Factors and JAK-STAT Pathway | ||
| 來源：SCI：Frontiers in Pharmacology | 作者：Yin Xiong, | 備注：影響因子：4.225 |
| 引用描述 | ||
Qualitative and quantitative analyses of SPN were performed as previous report (Xiong et al., 2017a). In brief, notoginsenoside R1 and ginsenosides Rg1, Re, 20(R)-Rh1, Rb1, Rd, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co., Ltd. Sichuan, China) with purity ≧ 98% were used as standard compounds. The analysis was performed on an Agilent 1260HPLC system (Agilent Technologies) equipped with a G1311B Pump, a G4212B DAD detector, and a G1329B autosampler. | ||
| An integrated strategy of MS-network-based offline 2DLC-QTOF-MS/MS coupled with UHPLC-QTRAP®-MS/MS for the characterization and quantification of the non-polysaccharides in Sijunzi decoction | ||
| 來源：SCI：ANALYTICAL AND BIOANALYTICAL CHEMISTRY | 作者：Dong, Bangjian | 備注：影響因子：4.157 |
| 引用描述 | ||
Liquiritin apioside, liquiritin, neoliquiritin, isoliquiritin apioside, isoliquiritin, ononin, naringin, liquiritigenin, poricoic acid A, poricoic acid B, poricoic acid C, glycyrrhetinic acid, dehydropachymic acid, pachymic acid, ginsenoside Re, ginsenoside Rg1, ginsenoside Rf, isoliquiritigenin, ginsenoside Rb1, ginsenoside Rg2, ginsenoside Rg3, ginsenoside Rg5, 20(S)-ginsenoside Rh1, notoginsenoside R1, ginsenoside Ro, ginsenoside Rc, formononetin, ginsenoside Rb2, glycyrrhizic acid, ginsenoside Rd, ginsenoside Rk1, and atractylenolide III were purchased from Chengdu DeSiTe Biological Technology Co., Ltd. (Chengdu, China) or Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, China). | ||
| Optimisation of Ethanol-Reflux Extraction of Saponins from Steamed Panax notoginseng by Response Surface Methodology and Evaluation of Hematopoiesis Effect | ||
| 來源：SCI：MOLECULES | 作者：Yupiao Hu | 備注：影響因子：3.098 |
| 引用描述 | ||
Acetonitrile of chromatographic grade and ferrous chloride and hydrogen peroxide of analytical grade were purchased from Merck Chemical Co. (Darmstadt, Germany). Notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rd, Rh1, Rk3, Rh4, 20(S)-Rg3, and 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co., Ltd. Chengdu, China) with a purity ≥ 98% were used as the standard compounds. | ||
![人參皂苷Rh1/人參皂甙Rh1/S-人參皂苷Rh1/(S型)人參皂苷Rh1/20(S)-人參皂苷Rh1/(20S)-人參皂苷Rh1/(2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-二羥基-17-((S)-2-羥基-6-甲基庚-5-烯-2-基)-4,4,8,10,14-五甲基十六氫-1H-環(huán)戊[a]菲-6-基)氧基)-6-(羥甲基)四氫-2H-吡喃-3,4,5-三醇](/image/145965)
![人參皂苷Rg2/20(S)-人參皂苷Rg2/人參皂甙Rg2/(S型)人參皂苷Rg2/人參皂苷Rg2-S型/(2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-二羥基-17-((S)-2-羥基-6-甲基庚-5-烯-2-基)-4,4,8,10,14-五甲基十六氫-1H-環(huán)戊[a]菲-6-基)氧基)-4,5-二羥基-6-(羥甲基)四氫-2H-吡喃-3-基)氧基)-6-甲基四氫-2H-吡喃-3,4,5-三醇/20S-人參皂苷Rg2](/image/145972)
